Eledon Pharmaceuticals (ELDN) Enterprise Value (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Enterprise Value of -$216.0 million for Q1 2026, down 72.99% year-on-year from -$800.0 million in Q1 2025, and down 62.02% on a QoQ basis from -$133.3 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Enterprise Value data on file, last reported at -$216.0 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 72.99% year-over-year to -$216.0 million; the trailing twelve-month figure through Mar 2026 stood at -$216.0 million (down 72.99% YoY), and the FY2025 full-year result was -$133.3 million, up 4.88% from the prior year.
- Enterprise Value for Q1 2026 stood at -$216.0 million, down from -$133.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$9.2 million in Q2 2022 and bottomed at -$216.0 million in Q1 2026.
- The 5-year median for Enterprise Value is -$83.6 million (2024), against an average of -$92.7 million.
- The widest annual swing landed in 2022, when Enterprise Value jumped 90.22%; it then plunged 1155.89% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$56.4 million in 2022, then climbed by 9.41% to -$51.1 million in 2023, then slumped by 174.31% to -$140.2 million in 2024, then increased by 4.88% to -$133.3 million in 2025, then plunged by 62.02% to -$216.0 million in 2026.
- The last three Enterprise Value figures came in at -$216.0 million (Q1 2026), -$133.3 million (Q4 2025), and -$183.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -216.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -216.04 Mn |
| Dec 31, 2025 | -133.34 Mn |
| Sep 30, 2025 | -183.13 Mn |
| Jun 30, 2025 | -107.57 Mn |
| Mar 31, 2025 | -124.88 Mn |
| Dec 31, 2024 | -140.18 Mn |
| Sep 30, 2024 | -78.19 Mn |
| Jun 30, 2024 | -83.61 Mn |
| Mar 31, 2024 | -80.11 Mn |
| Dec 31, 2023 | -51.10 Mn |
| Sep 30, 2023 | -115.54 Mn |
| Jun 30, 2023 | -101.83 Mn |
| Mar 31, 2023 | -9.40 Mn |
| Dec 31, 2022 | -56.41 Mn |
| Sep 30, 2022 | -9.20 Mn |
| Jun 30, 2022 | -9.20 Mn |
| Mar 31, 2022 | -76.68 Mn |
| Dec 31, 2021 | -84.83 Mn |
| Sep 30, 2021 | -94.04 Mn |
| Jun 30, 2021 | -9.20 Mn |
| Mar 31, 2021 | -9.20 Mn |
| Dec 31, 2020 | -9.20 Mn |
| Sep 30, 2020 | -10.10 Mn |
| Jun 30, 2020 | -8.76 Mn |
| Mar 31, 2020 | -8.76 Mn |
| Dec 31, 2019 | -8.79 Mn |
| Sep 30, 2019 | -10.81 Mn |
| Jun 30, 2019 | -13.70 Mn |
| Mar 31, 2019 | -13.70 Mn |
| Dec 31, 2018 | -12.97 Mn |
| Sep 30, 2018 | -16.32 Mn |
| Jun 30, 2018 | -19.19 Mn |
| Mar 31, 2018 | -22.52 Mn |
| Dec 31, 2017 | -17.37 Mn |
| Sep 30, 2017 | -19.16 Mn |
| Jun 30, 2017 | -22.59 Mn |
| Mar 31, 2017 | -24.40 Mn |
| Dec 31, 2016 | -1.13 Mn |
| Sep 30, 2016 | -18.63 Mn |
| Jun 30, 2016 | -12.16 Mn |
| Mar 31, 2016 | -14.30 Mn |
| Dec 31, 2015 | -24.02 Mn |
| Sep 30, 2015 | -33.17 Mn |
| Jun 30, 2015 | -59.08 Mn |
| Mar 31, 2015 | -94.16 Mn |
| Dec 31, 2014 | -105.26 Mn |
| Sep 30, 2014 | -105.46 Mn |
| Jun 30, 2014 | -21.15 Mn |
| Mar 31, 2014 | -27.01 Mn |
| Dec 31, 2013 | -31.75 Mn |
| Sep 30, 2013 | -23.11 Mn |